Pharmacology and Potential Use of Cyproterone Acetate
January 1977
in “
Hormone and metabolic research
”
TLDR Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.
The document discussed the pharmacology and potential use of Cyproterone Acetate, a synthetic steroidal anti-androgen. It highlighted its effectiveness in treating conditions related to androgen excess, such as severe acne, hirsutism, and androgenic alopecia. The paper also covered its mechanism of action, which involves blocking androgen receptors and reducing androgen production. Additionally, the document mentioned its use in prostate cancer therapy and as a component of hormone therapy for transgender women. The findings were based on clinical observations and trials conducted up to 1975.